The prevalence of cancer is growing exponentially, increased R&D activities related to cancer diagnosis. Beside this, factors such as infectious diseases and abnormalities in chromosomes are
/PRNewswire/ LumaBridge, (formerly known as Cancer Insight), an oncology-focused clinical research organization (CRO), today announced a majority growth.
LumaBridge Announces Growth Equity Investment From Summit Partners streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.